Poehling Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10	Closed	-$1K	–	144
2018 Q2	$1K	Buy	+10	New	+$1K	﹤0.01%	282